Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 10:02 am Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | Point72 Asset Management L.P. | 2,500 0.3% | 2,500 (New Position) | View |
2024-02-14 10:01 am Sale | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management L.P. | 788,545 3% | -1,335,655 (-62.88%) | View |
2024-02-14 08:56 am Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management L.P. | 822,334 3% | -743,495 (-47.48%) | View |
2024-02-14 07:16 am Purchase | 13G | FARFETCH LTD FTCHQ | Point72 Asset Management L.P. | 20,383,303 5.8% | 1,617,894 (+8.62%) | View |
2024-02-14 07:15 am Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management L.P. | 2,613,453 4.5% | -572,624 (-17.97%) | View |
2024-02-14 07:15 am Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | Point72 Asset Management L.P. | 3,202,381 4.7% | -268,310 (-7.73%) | View |
2024-02-14 07:01 am Sale | 13G | SEMTECH CORP SMTC | Point72 Asset Management L.P. | 1,684,160 2.6% | -2,976,676 (-63.87%) | View |
2024-02-14 07:01 am Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Point72 Asset Management L.P. | 2,834,499 3.3% | -685,903 (-19.48%) | View |
2024-02-14 07:00 am Sale | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | Point72 Asset Management L.P. | 2,552,822 3.2% | -1,508,521 (-37.14%) | View |
2024-02-14 06:45 am Sale | 13G | BIONOMICS LTD ADS BNOX | Point72 Asset Management L.P. | 59,580,000 4% | -59,512,680 (-49.97%) | View |
2024-02-14 06:45 am Sale | 13G | RAPID7 INC RPD | Point72 Asset Management L.P. | 1,877,611 3.1% | -1,214,659 (-39.28%) | View |
2024-02-14 06:30 am Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 3,997,545 4.5% | -87,999 (-2.15%) | View |
2024-02-14 06:30 am Sale | 13G | Chewy Inc. CHWY | Point72 Asset Management L.P. | 1,591,442 1.3% | -5,114,441 (-76.27%) | View |
2024-02-14 06:29 am Sale | 13G | Inari Medical Inc. NARI | Point72 Asset Management L.P. | 1,175,150 2% | -1,620,202 (-57.96%) | View |
2024-02-14 06:17 am Sale | 13G | Pulmonx Corp LUNG | Point72 Asset Management L.P. | 1,546,089 4% | -425,721 (-21.59%) | View |
2024-02-14 06:16 am Sale | 13G | IOVANCE BIOTHERAPEUTICS INC. IOVA | Point72 Asset Management L.P. | 468,821 0.2% | -7,646,069 (-94.22%) | View |
2024-02-14 06:15 am Sale | 13G | Fastly Inc. FSLY | Point72 Asset Management L.P. | 68,184 0.1% | -6,141,507 (-98.90%) | View |
2024-02-14 06:11 am Sale | 13G | Esperion Therapeutics Inc. ESPR | Point72 Asset Management L.P. | 209,971 0.2% | -4,323,785 (-95.37%) | View |
2024-02-14 06:03 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | Point72 Asset Management L.P. | 825,000 3.8% | -425,000 (-34.00%) | View |
2024-02-14 06:01 am Sale | 13G | CUTERA INC CUTR | Point72 Asset Management L.P. | 214,800 1.1% | -929,607 (-81.23%) | View |